exRNAdisease

Entry Detail

---



General Information

Database ID: exR0449894 RNA Name: GATAD2B RNA Type: mRNA Chromosome: chr1 Starnd: - Coordinate: Start Site(bp): 153789030 End Site(bp): 153923360 External Links: ENSG00000143614

Disease Information

Disease Name: Disease Category: MeSH ID: Type: Alias:

Expression Detail

GEO ID: GSE122377 Description: Tuberculous Meningitis in Pediatric Patients [CSF] Experimental Design: Disease Sample Source Case Disease Type: Pediatric TB meningitis Case Disease SubType: NA Case Sample: Ventricular Cerebrospinal Fluid Control Sample: Lumbar Puncture Cerebrospinal Fluid Number of Case: 12 Number of Control: 12 Number of Samples: 24

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand AC012309.1 chr19 37093019 37210512 - AC048338.1 chr12 122207779 122266423 - AC116366.3 chr5 132410832 132646079 + ACACB chr12 109116595 109268226 + AGTPBP1 chr9 85546539 85742029 - AKT1S1 chr19 49869033 49878459 - miRNA targets: miRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa-miR-23a-3p chr19 13836595 13836615 - hsa-miR-29a-3p chr7 130876748 130876769 - hsa-miR-23b-3p chr9 95085265 95085287 + hsa-miR-185-5p chr22 20033153 20033174 + hsa-miR-29c-3p chr1 207801865 207801886 - hsa-miR-34c-5p chr11 111513451 111513473 + hsa-miR-449a chr5 55170586 55170607 - hsa-miR-641 chr19 40282603 40282626 - hsa-miR-663a chr20 26208243 26208264 - hsa-miR-449b-5p chr5 55170706 55170727 - hsa-miR-483-5p chr11 2134181 2134202 - hsa-miR-1321 chrX 85835832 85835849 + circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC004834.1 chr7 99252452 99325826 - Display:

Experiment Detail

GEO ID: NA Sample Source: NA Source Fraction: NA Platform: NA Method: NA Num of detected RNA Type: NA Num of detected RNAs of this Type: NA Sample treatment protocol: NA RNA Extract protocol: NA RNA library preparation protocol: NA

Reference

PMID: 31434901 Title: Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity Author: Rohlwink UK, Figaji A, Wilkinson KA, Horswell S, Sesay AK, Deffur A, Enslin N, Solomons R, Van Toorn R, Eley B, Levin M, Wilkinson RJ, Lai RPJ Journal: Nat Commun. 2019 Aug 21;10(1):3767. Description: Differential transcript expression of TBM cases are compared with healthy controls in whole blood and with non-TB cerebral infection controls in CSF.